Introduction {#sec1-1}
============

Carpal tunnel syndrome (CTS) is a common entrapment neuropathy of the median nerve at the wrist. The symptoms include pain, paresthesia and numbness in the hand area supplied by the median nerve. The pain may radiate proximally and may be more at night. Less commonly, patients may develop the motor symptoms such as difficulty in gripping or objects falling out of the hand. The treatment of CTS includes non-surgical modalities such as splinting, analgesics, oral steroids, local steroids and for severe disease and surgery.\[[@ref1]\] The use of local steroid injections have been mentioned in the literature as early as 1980.\[[@ref2]\] A Cochrane review by Marshall *et al*. in 2007 concluded that local corticosteroid injection for severe CTS provided symptomatic benefit after 1 month compared with placebo.\[[@ref3]\] The effect on mild to moderate CTS could not be concluded due to inadequate evidence. Comprehensive guidelines based on available studies provided by the American Academy of Orthopedic Surgeons (2008) suggest the use of local steroid injections prior to considering surgery.\[[@ref4]\] These recommendations are based on studies, which have used symptomatic improvement as the primary outcome. Objective electrophysiological parameters showing improvement after local steroid injection has been demonstrated only in very few studies. Some of the short coming of these studies included a small sample size, poorly defined and varied electrophysiological criteria for improvement, exclusion of severe CTS and exclusion of cases with comorbidities.\[[@ref5][@ref6][@ref7][@ref8][@ref9][@ref10]\] There is a need to identify electrophysiological parameter (s), which can be relied upon to document a change and can be used for follow-up after a local steroid injection.

We undertook this study with the following aims:

To evaluate the changes in the electrophysiological parameters 1 month after local steroid injection in patients with CTS irrespective of the severityTo identify an electrophysiological parameter that can be consistently relied upon to demonstrate improvement and follow-up patients 1 month after local steroid injection across the severity spectrum of CTS.

Materials and Methods {#sec1-2}
=====================

All patients referred to the Neurology Out-patient Department of a Tertiary Care Hospital between January 2010 and March 2012 with a presumptive clinical diagnosis of CTS was subjected to electrophysiological studies. Electrophysiology was done by the first author on all patients using a synergy machine. Surface electrodes were used for recording. Due to precautions were taken to keep the hands warm at around 32-33°C; however, temperature monitoring during the procedure could not be done. Orthodromic technique of stimulation was used to record sensory parameters at the wrist with median nerve being stimulated at second digit and ulnar nerve at the fifth digit. Mid palm stimulation was also done for both the nerves 8 cm from the recording site at the wrist. Sensory parameters recorded for both nerves included onset latencies, amplitude of sensory nerve action potentials (SNAPs) and conduction velocities (CVs) from both stimulating sites. Motor recording was done using abductor pollicis brevis (APB) for median nerve and abductor digiti minimi for the ulnar nerve. Stimulation was done distally at the wrist and proximally at the elbow. Motor parameters included distal motor latencies, amplitude of compound muscle action potential (CMAPs) and CV. Electrophysiological diagnosis of CTS was made as per the recommendations given by the American Association of Electrodiagnostic Medicine in 2002.\[[@ref11]\] Electrophysiological grading was carried out for all patients as per a scale given by Bland.\[[@ref12]\] This study documented the distribution of patients on a scale based upon the nerve conduction study findings, which were independent of the exact normal values. The author demonstrated a highly significant linear relationship between the neurophysiological grading and a numerical score derived from the clinical history. The scale is as follows: Normal (Grade 0); very mild (Grade 1), CTS demonstrable only with most sensitive tests; mild (Grade 2), sensory nerve CV slow on finger/wrist measurement, normal terminal motor latency; moderate (Grade 3), sensory potential preserved with motor slowing, distal motor latency to APB \< 6.5 ms; severe (Grade 4), sensory potentials absent but motor response preserved, distal motor latency to APB \< 6.5 ms; very severe (Grade 5), terminal latency to APB \> 6.5 ms; extremely severe (Grade 6), sensory and motor potentials effectively unrecordable (surface motor potential from APB \< 0.2 mV amplitude).\[[@ref12]\]

All patients diagnosed to have CTS on electrophysiology and who were willing to take a local steroid injection were included in the study. Exclusion criteria were as follows: Previous surgery for CTS, previous local steroid injection, use of oral steroids, Grade 6 (extremely severe) CTS and patients unwilling for local steroid injection. Informed consent was taken from each patient prior to injection. The presence of any comorbidity and symptom (s) at presentation were also documented.

By using the aseptic technique, 1 ml of injection triamcinalone (40 mg/ml) was injected using a tuberculin syringe and a 26-gauge needle. The site of the injection was at the proximal crease of the wrist just medial to the palmaris longus tendon with the needle angled at 45° towards the palm and directed slightly medially.

One month after the injection the patients were reviewed. During this period, patients were not permitted to use any other form of therapy like splints or drugs. Patients were first asked to subjectively quantify the degree of improvement (if any) on a visual analog scale (VAS) of 100 on one parameter for which they were most symptomatic prior to the injection. The parameter could include pain, tingling, numbness, nocturnal awakenings or functional improvement. Electrophysiology studies were repeated and the previously mentioned parameters were recorded.

The primary outcome was change in distal motor latency in the median nerve at 1 month after the local injection. The secondary end points were a VAS score of improvement of symptom by at least 50%, change in amplitude of CMAP and motor CV. A VAS score of improvement of symptoms of lesser than 50% was taken as failure. The motor parameters were preferred over sensory since they were recordable from Grade 1 to Grade 5 CTS (Grade 6 was excluded). CTS is an entrapment neuropathy with features of focal demyelination where out of the motor parameters the distal motor latency is likely to be most affected. Hence, this was chosen as the primary end point. Sensory parameters were not taken as they are not recordable in Grade 4 or more CTS. A subgroup analysis was done in mild to moderate CTS (defined as Grade 3 or less) for significant change in sensory onset latency, amplitude of SNAP, sensory CV, distal motor latency, amplitude of CMAP and motor CV. Also in another subgroup consisting of severe and very severe CTS (Grades 4 and 5) the change in distal motor latency, amplitude of CMAP and motor CV were also seen.

Statistical analysis was performed using paired *t* test to look for a significant difference in the electrophysiological values of each parameter at baseline, which were compared with those at 1 month after a local steroid injection. A *P* \< 0.05 was considered as significant. SPSS software version 17 was used for analysis.

Results {#sec1-3}
=======

Over a 2 year period, 67 patients were screened and 47 patients were selected. 10 patients did not have CTS while four gave previous history of local steroid injection and three of surgery. Three had extremely severe CTS with both SNAPs and CMAP not recordable and hence were excluded. In the study, 27 out of 47 patients selected had bilateral CTS hence 74 hands were included. The baseline characteristics of the patients are given in [Table 1](#T1){ref-type="table"}. Nearly, 87% of our patients were females. Majority (85%) had Grades 2, 3 or 4 disease and a quarter of our patients had some comorbidity associated. Pain and tingling were the most common symptom at presentation as shown in [Table 2](#T2){ref-type="table"}.

###### 

Baseline characteristics
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###### 

Symptom frequency at presentation
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All patients met the criteria of symptomatic success by reporting a VAS score of symptomatic improvement of at least 50%. 54 hands (73%) reported 100% improvement at 1 month in at least one symptom parameter as shown in [Table 3](#T3){ref-type="table"}.

###### 

VAS score (out of 100) of symptomatic improvement one month after injection in 74 hands
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Mean baseline and follow-up motor parameter in all 74 hands are shown in [Table 4](#T4){ref-type="table"}. The distal motor latency improved by 9.5% 1 month after local steroid injection and this was found to be highly significant by paired *t*-test. The motor CV and amplitude showed some improvement, but this was not found to be significant.

###### 

Baseline and follow-up median nerve mean motor parameters one month after the injection in 74 hands
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A subgroup analysis on mild to moderate CTS (Grade 3 or less) in 52 hands showed distal motor latency to improve by 10.3% from the baseline, which was highly significant by paired *t*-test. However, the motor CV and amplitude showed no significant improvement. All the sensory parameter showed a significant improvement and this is shown in greater detail in [Table 5](#T5){ref-type="table"}.

###### 

Baseline and follow-up median nerve mean motor and sensory parameters one month after the injection in mild CTS (52 hands)
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A subgroup analysis was also performed in 22 hands with severe (Grade 4) and very severe (Grade 5) CTS as shown in [Table 6](#T6){ref-type="table"}. The distal motor latency improved by 9.4% and the motor amplitude improved by 35%, which were found to be significant by paired *t* test. The motor CV too showed a 15% improvement although on paired *t* test analysis this was not found to be significant \[[Table 4](#T4){ref-type="table"}\]. Sensory parameters were not recordable prior to the injection, but after 1 month the injection 10 out of these 22 hands had recordable sensory parameters, however, these have not been analyzed.

###### 

Baseline and follow up median nerve mean motor parameters one month after the injection in severe CTS (22 hands)
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Discussion {#sec1-4}
==========

After 1 month, a local steroid injection for CTS all our patients irrespective of the severity reported subjective improvement in one parameter for which they were most symptomatic prior to the injection. Our study also showed that there is a significant improvement in distal motor latency consistently irrespective of the severity of the CTS. We have also demonstrated that in mild to moderate CTS (Grade 3 of Bland) in addition to distal motor latencies there is a significant improvement in all sensory parameters recorded, which include onset latency, amplitude of SNAP and sensory CV. However, amplitude of CMAP and motor CV did not show a significant improvement. In severe to very severe CTS (Grades 4 and 5) in addition to distal motor latencies there is an improvement in motor CV with the amplitude of CMAP showing a trend toward improvement.

These findings can be explained on the pathophysiological basis of entrapment neuropathy, which is focal demyelination. Early electrophysiological changes (sensory or motor) in focal demyelination are marked by latency prolongation and slowing of CV. Onset of axonal loss is usually marked by the drop in amplitude. In the course of the natural history of CTS sensory parameters are affected earlier and more severely than motor parameters and are soon not recordable. The distal motor latencies too are affected early with prolongation, but stay within the "normal limits." As the severity of the entrapment worsens further prolongation takes place beyond the "normal limits" and focal slowing of motor CV appears. Loss of amplitude of CMAP will take place only in very severe cases once significant axonal loss has started. This was seen in our study too where after a local steroid injection the sensory parameters, although sensitive were not recordable in Grades 4 or 5 CTS and could not be relied upon to document improvement. Among the motor parameters, the distal motor latencies were recordable from Grades 1 to 5 and showed the most consistent improvement. Other motor parameters were not reliable in our study.

So far, following a local steroid injection for CTS, there are no clearly defined electrophysiological parameters for outcome assessment. This stems from the fact that the various studies have used different severity scales for grading CTS, recruited only mild CTS (with intact sensory parameters), defined heterogeneous outcome assessment parameters and various time frames at which assessment was carried out. Giannini *et al*. found that local injection of triamcinolone (40 mg) in addition to providing symptomatic relief improved distal motor and sensory latencies of the median nerve at the wrist.\[[@ref5]\] Agarwal *et al*. recruited mild CTS defined as distal motor latencies \<7.5 ms with assessment of multiple parameters, severe CTS and patients with comorbidities were excluded.\[[@ref10]\] Hagebeuk and de Weerd too had multiple electrophysiological parameters and demonstrated improvement in sensory latencies, SNAP, sensory CV and CMAP at 6 months, but this was in mild CTS.\[[@ref8]\] A study on a pregnant woman with CTS by Moghtaderi *et al*. showed improvement in sensory CV, sensory and motor latency at 3 weeks.\[[@ref7]\] Ayhan-Ardiç and Erdem demonstrated improvement in sensory latencies, amplitude, CV and motor distal latencies at 3 weeks and 3 months in 20 hands.\[[@ref6]\] The studies by Armstrong *et al*.,\[[@ref13]\] Celiker *et al*.,\[[@ref14]\] Lucantoni *et al*.\[[@ref15]\] and O'Gradaigh and Merry\[[@ref16]\] used electrophysiological parameters only as a secondary outcome.

After 1 month, a local steroid injection symptomatic improvement has been documented earlier and also in our study.\[[@ref3]\] However, symptom severity does not necessarily correlate with electrophysiological severity, a relatively symptomatic patient may have a mild disease or a patient with severe CTS on electrophysiology may have mild symptoms. Hence, an objective parameter, which consistently improves after a local steroid injection irrespective of the grade of CTS, is necessary to follow-up patients and also for future studies. We found that distal motor latency is the most consistent electrophysiological parameter showing improvement in all grades of severity of CTS. Sensory parameters although useful in mild to moderate CTS are not recordable in more severe disease and cannot be relied upon for follow-up.

We chose to assess electrophysiological parameters the 2^nd^ time at 1 month because it has been noted earlier that symptomatic response usually starts at 2 weeks.\[[@ref13]\] Peak response usually occurs at 1 month.

Conclusion {#sec1-5}
==========

Our study has demonstrated that 1 month following a local steroid injection for CTS distal motor latency was the electrophysiological parameter, which showed the most consistent and reliable improvement irrespective of the severity of CTS. This observation can be used to objectively follow-up patients following a steroid injection for the duration of improvement and also document relapse. These findings can also be used to plan future studies using the local steroid injections. They can also be extrapolated to objectively follow-up patients following surgery for CTS. The limitations of our study include lack of controls and follow-up limited to 1 month. Future studies can be planned to overcome these limitations.
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